Inecient inhaler technique is a common problem resulting in poor drug delivery, decreased disease control and increased inhaler use. The aim of this study was to assess patients' use of dierent inhaler devices and to ascertain whether patient preference is indicative of ease of use and whether current inhaler use has any in¯uence on either technique or preference. We also wished to de®ne the most appropriate method of selecting an inhaler for a patient, taking into account observed technique and device cost. One hundred patients received instruction, in randomized order, in the use of seven dierent inhaler devices. After instruction they were graded (using predetermined criteria) in their inhaler technique. After assessment patients were asked which three inhalers they most preferred and which, if any, they currently used. Technique was best using the breath-actuated inhalers; the Easi-Breathe 1 and Autohaler 1 , with 91% seen to have good technique. The pressurized metered dose inhaler (pMDI) fared poorly, in last position with only 79% of patients showing good technique, despite being the most commonly prescribed. The Easi-Breathe 1 was by far the most popular device with the patients. The Autohaler 1 came in second position closely followed by the Clickhaler 1 and Accuhaler
Introduction
Inhaled bronchodilator therapy is often used in the treatment of both chronic obstructive airways disease (COAD) and asthma. However, with the conventional pMDI, inecient inhaler use is a common problem with many patients unable to co-ordinate actuation of the device with inhalation (1) . This in turn, can result in poor drug delivery, decreased disease control and increased inhaler use. This problem obviously has cost implications, both in terms of medication, visits to the GP, and hospital admissions. If time is spent in the education of inhaler use, these costs can be reduced (2) . By assessing which inhaler devices patients can use eciently and prescribing appropriately, the delivery of drug can be maximized.
Patient preference may also be useful for assessing acceptance and hence compliance with a device.
Method
Between March and December 1998, a total of 100 patients (52 male, 48 female, ages 22±88 years) were referred to the Respiratory Function Laboratory for inhaler assessment. Patients attended from a number of referral sources within the hospital (64 patients) and from the Open Access GP service (36 patients). All patients had a clinical diagnosis of air¯ow obstruction although the severity varied. However, 33% of the patients had an FEV 1 equal to or less than 1Á00 l. Prior knowledge of inhaler devices varied from patient to patient. Some patients were referred because of diculty using their current inhaler whereas others had no experience using inhaler devices.
For the inhaler assessment, seven dierent inhaler devices were used; pMDI, pMDI+Volumatic Inhaler assessments were carried out by all the laboratory sta. To ensure that grading remained consistent members of sta referred to a predetermined protocol which stipulated which faults constituted dierent gradings for each device. The criteria for grading the inhaler assessment are summarized in Table 1 . In addition, the order of presentation of devices was randomized to ensure that there was no bias for any one device. Inhaler technique was then graded in the following way;
A. good technique indicating good delivery of the drug; B. poor technique indicating partial delivery of the drug; C. very poor technique indicating little or no delivery of the drug.
At the end of assessment patients were asked which devices they would most prefer to use by indicating their ®rst, second and third choice. A scoring system was used to evaluate patient preference with; ®rst choice=3 points, second choice=2 points and third choice=1 point. The points were then added to give an overall score for each device.
Finally patients were asked which, if any, inhalers they currently used to see if this had an eect on either assessment grades or preference.
Results Table 2 shows the assessment grades for the dierent devices. Ninety-one percent of patients achieved grade A technique with the Easi-Breathe 1 and Autohaler 1 . Failure to trigger the device and cough were the most common problems. For the powder devices, fewer patients achieved grade A with the Turbohaler 1 compared to either the Accuhaler 1 or Clickhaler 1 , although these dierences are not statistically signi®cant due to the small number of patients grading B and C. The most common problems for the powder devices were failure to prime correctly and slow inspiration. The pMDI, despite being commonly prescribed, fared poorly with only 79% of patients grading A immediately after expert tuition, compared to 91% grading A with the Easi-Breathe 1 and the Autohaler 1 breath activated devices (P50Á02 in both cases, McNemar's test). The most common problem was poor co-ordination, patients unable to co-ordinate actuation of the device with inspiration. This fault was remedied in some patients by the addition of a large volume spacer, the Volumatic 1 , which increased the number of patients graded A to 87%, however, the pMDI/Volumatic 1 combination was unpopular with patients (see Table 3 ). Table 3 illustrates the patients' preferences for dierent devices. The Easi-Breathe 1 was the most popular device with the Autohaler 1 in second position closely followed by the
Of the 100 patients assessed, 87 expressed a preference with 64 patients able to state their ®rst, second and third choice, 20 patients able to state their ®rst and second choice and three patients stating one preferred device. Thirteen patients felt unable to express a preference rating all the devices as equal. Of these 13 patients, many could use the devices equally well but a few patients who could not use their prescribed device still did not express a preference even though they were able to use other devices better. Table 4 shows the current inhaler use in the patient sample. Of the 100 patients, 67 patients had known current inhaler use with 16 of these patients using more than one device. The majority (55) were using pMDI at the time of assessment.
Does current inhaler use in¯uence patient preference? Table 5 shows the preferences of two groups of patients within the sample. The ®rst group are sole pMDI users and the second group are on no inhalers. For both groups the Easi-Breathe 1 was the top choice. Being a current user of a pMDI did not make patients any more likely to choose the pMDI or any other aerosol device as their preferred device. In contrast, the pMDI was considerably more popular in the group of patients on no inhaler device. Table 6 considers the same two groups of patients to see if current inhaler use has an eect on inhaler technique. As can be seen from the table the sole pMDI users generally achieved poorer grades than the inhaler-naive group.
Discussion
Of the pressurized devices, the breath-actuated models emerged as the preferred devices for the majority of patients (3, 4) ] mean that patients with severe air¯ow obstruction can use these devices when they may have insucient inspiratory¯ow for other devices (4). The breath-actuated inhalers fared signi®cantly better than the conventional pMDI despite the fact that 55% of the patients were already using pMDIs and had just received further instruction. This has been corroborated by previous studies which have shown that patients can be taught how to use breath-actuated inhalers to a greater degree of eciency than the conventional pMDI (5±7). Of the 55 patients using the pMDI only 40 graded A (ecient) and 15 patients were unable to use the device eciently (three patients graded B, 12 patients graded C). However, 10 of these patients were able to use a breath-actuated inhaler to grade A.
Clearly, in a hospital setting it is possible that our sample was biased because some patients were referred after their clinicians noted diculty with inhaler technique whereas other patients were referred to establish the most suitable device prior to prescription. It appears from Table 6 that the sole pMDI users clearly had more of a problem with inhaler technique than the inhaler naive group. The number of patients achieving grade A for pMDIs in the two groups re¯ects this.
There is some correlation between inhaler grade and preference in that the top four most popular inhaler devices also achieved the best grades for technique. In addition, when we looked at inhaler technique in the inhaler devices currently used, only 64 out of a total of 80 devices were used eciently (Grade A). In contrast, where a preference was stated, all patients graded A with the inhaler of their choice. However, caution needs to be applied to those patients not expressing a preference, since ®ve out of 11 of the current inhaler users who did not express a preference could not use their device eciently.
What would be the cost implications of prescribing patients their preferred device? For the patients studied the cost of 100 adult doses (short-acting ( 2 -agonists only) of each device was calculated for current inhaler use and preferred inhaler devices. Patients not on any of the devices assessed were excluded and for patients with no preference Easi-Breathe 1 was selected. Costs for the preferred device were then expressed as a percentage of the cost of 100 doses of patients' current inhaler. Prescribing patients' preferred devices would incur an 81% increase in cost (8) . However, although necessitating additional cost in the short term, it is important to remember that any increased eciency may be cost eective in the long term through decreased frequency of`as required' doses.
An alternative approach would be to prescribe the pMDI where technique is adequate (A) and the patient's preferred device when it is not. This would result in a reduction in cost of 14%, mainly because some patients already using costly devices have good technique with a basic pMDI. The improved drug delivery could reduce costs still further.
Good inhaler technique is vital for a drug to be eective and bearing in mind the wide range of drugs used for treatment of respiratory conditions e.g., 2 -agonists, 
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anti-cholinergics and corticosteroids, the cost of misuse can be signi®cant. If patients are not using their inhalers correctly the need for increased dosages, systemic steroids and regular visits to the doctor may ensue. Only 79% of patients tested could use the pMDI eciently even after instruction but it continues to be the most commonly prescribed. Patient education should play an important part in the provision of inhaler devices. If, following expert tuition, patients express a preference for a particular device this usually correlates with good technique and may promote compliance. In all cases technique should be assessed by direct observation after expert instruction. 
